One could argue that a difference in BP might eventually develop outside the time scale of our protocol, but this idea is challenged by the complicated pathophysiology of Ang II hypertension and the multisystemic mechanisms by which Ang II causes hypertension. This evidence concerns the gene ANG and hypertensive disorder.